AWM
MRNA icon

Avaii Wealth Management’s Moderna MRNA Stock Holding History

Avaii Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,336
Closed -$2.65M – 145
2024
Q2 		$2.65M Buy
+22,336
New +$2.83M 1.47% 18
2023
Q3 		– Sell
-4,967
Closed -$603K – 148
2023
Q2 		$603K Buy
4,967
+2,141
+76% +$286K 0.46% 51
2023
Q1 		$434K Buy
2,826
+539
+24% +$88.9K 0.38% 59
2022
Q4 		$411K Sell
2,287
-846
-27% -$138K 0.37% 65
2022
Q3 		$370K Buy
3,133
+291
+10% +$44.2K 0.38% 63
2022
Q2 		$406K Buy
2,842
+380
+15% +$54.3K 0.43% 43
2022
Q1 		$424K Buy
+2,462
New +$414K 0.39% 47

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Avaii Wealth Management's MRNA Position: Q3 2024 in Review

Avaii Wealth Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 22,336 shares — an estimated $2.65M sold.

Avaii Wealth Management first reported a position in MRNA in Q1 2022 and held it in 7 quarters. The position peaked at $2.65M in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Avaii Wealth Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Avaii Wealth Management sold 22,336 Moderna shares in Q3 2024, an estimated $2.65M.
  • Avaii Wealth Management first reported a position in Moderna in Q1 2022 and held it in 7 quarters.
  • Avaii Wealth Management's Moderna position peaked at $2.65M in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Avaii Wealth Management's 13F filing for Q3 2024, filed 16 Oct 2024.